1. Home
  2. PRME vs HNRG Comparison

PRME vs HNRG Comparison

Compare PRME & HNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

SELL

Current Price

$4.23

Market Cap

526.0M

Sector

Health Care

ML Signal

SELL

HNRG

Hallador Energy Company

SELL

Current Price

$10.09

Market Cap

552.0M

Sector

Energy

ML Signal

SELL

Company Overview

Basic Information
Metric
PRME
HNRG
Founded
2019
1949
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Coal Mining
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
526.0M
552.0M
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
PRME
HNRG
Price
$4.23
$10.09
Analyst Decision
Buy
Strong Buy
Analyst Count
13
3
Target Price
$7.03
★ $28.00
AVG Volume (30 Days)
★ 5.5M
1.1M
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
18.18
★ 116.78
EPS
N/A
★ N/A
Revenue
$4,632,000.00
★ $469,466,000.00
Revenue This Year
$18.58
N/A
Revenue Next Year
$23.34
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 55.28
16.09
52 Week Low
$2.67
$8.85
52 Week High
$5.91
$23.44

Technical Indicators

Market Signals
Indicator
PRME
HNRG
Relative Strength Index (RSI) 51.32 38.34
Support Level $2.94 $8.85
Resistance Level $4.80 $12.11
Average True Range (ATR) 0.53 0.74
MACD -0.08 0.11
Stochastic Oscillator 22.25 37.32

Price Performance

Historical Comparison
PRME
HNRG

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

About HNRG Hallador Energy Company

Hallador Energy Co is a vertically integrated, independent power producer (IPP) and fuel company with operations in Indiana. The Company operates across multiple stages of the energy value chain, from accredited capacity and energy to coal. The Company's electric operations are located within the Midcontinent Independent System Operator's (MISO) footprint. The company's business is organized based on the services and products it provide in two segments: (i) Electric Operations and (ii) Coal Operations.

Share on Social Networks: